Genix Pharmaceuticals Corporation

Genix Pharmaceuticals Corporation

GENPF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$844.89K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Genix Pharmaceuticals CorporationGenix Pharmaceuticals Corporation-5.1-18%--0.5
$-0.01

Current Fair Value

176% downside

Overvalued by 176% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$844,893.00
Enterprise Value$1.60 Million
Earnings per Share$-0.01
Beta0.4
Outstanding Shares61,224,131

Return

Return on Equity18.25%ROE
Return on Assets-847.70%
Return on Invested Capital7.49%

Valuation & Multiples

P/E Ratio-5.08P/E Ratio
PEG-10.01PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.01Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-13.82
Enterprise Value to Net Income-6
Total Debt to Enterprise0.48
Debt to Equity-0.5Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
October 29, 2026
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Genix Pharmaceuticals Corporation

4,000 employees
CEO: Sina Salehi Pirooz

Genix Pharmaceuticals Corporation, established in 1993 and headquartered in Vancouver, Canada, is actively involved in the creation, production, licensing, and distribution of various life science products. The company's primary focus in...